ASX · AVR.AX
Anteris Technologies Ltd
A$8.83+A$0.28 (+3.27%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
Loading market information…
OTC · CKMTF · USD
Stock price, earnings
Quote as of Nov 18, 2022, 04:11 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Carmat S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoublay, France.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $1.39M |
| Q4 2020 | Feb 10, 2021 | -$1.74 | $5.52K |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$8.83+A$0.28 (+3.27%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
¥584-¥3 (-0.51%)
Japan Medical Dynamic Marketing, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.89% below the high.
$0.06$0.00 (0.0%)
Respiri Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.51+$0.46 (+971.88%)
Mind Cure Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$1.26-$0.04 (-2.77%)
Nova Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 3.36% below the high.
$0.13$0.00 (0.0%)
E-therapeutics Plc: Healthcare · Biotechnology.
$3.99$0.00 (0.0%)
RetinalGenix Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.25% below the high.
$1.00$0.00 (0.0%)
Taihe Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.7% below the high.
